Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine

Journal of Epidemiology and Community Health

Volumn 53, Issue 3, 1999, Pages 173-178

  Paunio, Mikko ^a   Peltola, Heikki ^a   Valle, Martti ^b   Davidkin, Irja ^b   Virtanen, Martti ^b   Heinonen, Olli P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; EPIDEMIC; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MEASLES VACCINATION; PROTECTION; REGISTER; REVACCINATION; RURAL AREA; SERODIAGNOSIS;

EID: 0032976705     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.3.173     Document Type: Article

References (68)

1. US Preventive Services Task Force. Immunizations and chemoprophylaxis. Childhood immunizations. In: DiGuiseppi C, Atkins D, Woolf SH, eds. Guide to clinical preventive services. 2nd ed. Baltimore: Williams and Wilkins, 1996:767-90.
2. World Health Organization. Expanded Programme on Immunization (EPI) - Measles Control in the WHO African Region. Weekly Epidemiological Record. Number 26, 201-3: June 26, 1996.
3. Brunell PA, Weigle K, Murphy D, et al. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983;250:1409-12.
4. Peltola H, Karanko V, Kurki T, et al. Rapid effect of endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet 1986;i:137-9.
5. Paunio M, Virtanen M, Peltola H, et al. Increase of vaccination coverage by mass media and individual approach: Intensified measles, mumps, and rubella prevention program in Finland. Am J Epidemiol 1991;133:1152-60.
6. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps, and rubella by a 12-year, two-dose vaccination program. N Engl J Med 1994;331:1397-402.
7. Reyes MA, de Borrero MF, Roa J, et al. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987;6:848-51.
8. Mathias RG, Meekison WG, Arcand TA, et al. The role of secondary vaccine failure in measles outbreaks. Am J Public Health 1989;79:475-8.
9. Markowitz LE, Preblud SR, Fine PEM, et al. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990;9:101-10.
10. Gershon AA, Krugman S. Measles virus. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. 5th ed. Washington, DC: American Public Health Association, 1979:685-6.
11. Fox JP, Elveback L, Scott W, et al. Herd immunity: basic concept and relevance to public health immunization practices. Am J Epidemiol 1971;94:179-89.
12. Mehta CR, Patel NR, Gray R. Computing of an exact confidence interval for the common odds ratio in several 2x2 contingency tables. Journal of the American Statistical Association 1985;80:969-73.
13. Schlesselman JJ. Basic methods of analysis. In: Case-control studies. Design, conduct, analysis. New York: Oxford University Press, 1982:171-226.
14. Paunio M, Peltola H, Valle M, et al. Explosive school-based measles outbreak-intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol (in press).
15. Pedersen IR, Modhorst CH, Glikmann G, et al. Subclinical infection in vaccinated seropositive individuals in Arctic Greenland. Vaccine 1989;7:345-8.
16. Boulianne N, De Serres G, Ratnam S, et al. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: Effect of vaccine type and age at vaccination. Vaccine 1995;13:1611-16.
17. André FE. Thermodegradation of lyophilized measles vaccines. Rev Infect Dis 1983;5:532-4.
18. Klamm H, Pollex G, Henning U. Thermal inactivation of different measles virus strains. Acta Viral 1991;35:200-2.
19. Lerman SJ, Gold E. Measles in children previously vaccinated against measles. JAMA 1971;216:1311-14.
20. McIntyre RC, Preblud SR, Polloi A, et al. Measles and measles vaccine efficacy in a remote island population. Bull World Health Organ 1982;60:767-75.
21. Rawls WE, Rawls ML, Chernesky MA. Analysis of a measles epidemic; possible role of vaccine failures. Can Med Assoc J 1975;113:941-4.
22. Shasby DM, Shope TC, Downs H, et al. Epidemic measles in a highly vaccinated population. N Engl J Med 1977;296: 585-9.
23. Marks JS, Halpin TJ, Orenstein WA. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics 1978;62:955-60.
24. Shelton JD, Jacobson JE, Orenstein WA, et al. Measles vaccine efficacy: Influence of age at vaccination vs. duration of time since vaccination. Pediatrics 1978;62:961-4.
25. Riley EC, Murphy G, Riley RL. Airborne spread of measles in a suburban elementary school. Am J Epidemiol 1978;107:421-32.
26. Center for Disease Control and Prevention. Measles outbreak among vaccinated high school students - Illinois. MMWR 1984;33:349-51.
27. Wassilak SGF, Orenstein WA, Strickland PL, et al. Continuing measles transmission in students despite a school-based outbreak control program. Am J Epidemiol 1985;122:208-17.
28. Hull HF, Montes JM, Hays PC, et al. Risk factors for measles vaccine failure among immunized students. Pediatrics 1985;76:518-23.
29. Davis RM, Whitman ED, Orenstein WA, et al. A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol 1987;126:438-49.
30. Nkowane BM, Bart SW, Orenstein WA, et al. Measles outbreak in a vaccinated school population: Epidemiology, chains of transmission and the role of vaccine failures. Am J Public Health 1987;77:434-8.
31. Hutchins SS, Markowitz LE, Mead P, et al. A school-based measles outbreak: The effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol 1990;132:157-68.
32. Mast EE, Berg JL, Hanrahan LP, et al. Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA 1990;264: 2529-33.
33. Hersch BS, Markowitz LE, Hoffman RE, et al. A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health 1991;81:360-4.
34. Osterman JW, Melnychuk D. Revaccination of children during school-based measles outbreaks: Potential impact of a new policy recommendation. Can Med Assoc J 1992;146: 929-36.
35. Robertson SE, Markowitz LE, Berry DA, et al. A million dollar measles outbreak - epidemiology, risk factors, and a selective revaccination strategy. Public Health Rep 1992;107: 24-31.
36. Yuan L. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy. Can Med Assoc J 1994;150:1093-8.
37. Gustafson TL, Lievens AW, Brunell PA, et al. Measles outbreak in a fully immunized secondary-school population. N Engl J Med 1987;316:771-4.
38. Markowitz LE, Preblud SR, Orenstein WA, et al. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med 1989;320:75-81.
39. Chen RT, Goldbaum GM, Wassilak SGF, et al. An explosive point-source measles outbreak in a highly vaccinated population. Am J Epidemiol 1989;129:173-82.
40. Fescharek R, Quast U, Maass G, et al. Measles-mumps vaccination in the FRG: An empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures. Vaccine 1990;8:333-6.
41. Agocs MM, Markowitz LE, Straub I, et al. The 1988-1989 measles epidemic in Hungary: Assesment of vaccine failure. Im J Epidemiol 1992;21:1007-13.
42. Poland GA, Jacobsen RM, Thampy AM, et al. Measles reimmunization in children seronegative after initial immunization JAMA 1997;277:1156-8.
43. Guris D, Mccready J, Watson JC, et al. Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus. Pediatr Infect Dis J 1996;15:1082-6.
44. Tulchinsky TH, Ginsberg GM, Abed Y, et al. Measles control in developing and developed-countries: The case for a 2-dose policy. Bull World Health Organ 1993;71:93-103.
45. Crawford GE, Gremillion DH. Epidemic measles and rubella in air force recruits: impact of immunization. J Infect Dis 1981;144:403-10.
46. Rosenthal SR, Clements CJ. Two-dose measles vaccination schedules. Bull World Health Organ 1993;71:421-8.
47. Anderson RM, May RM. Directly transmitted infectious diseases: control by vaccination. Science 1982;215:1053-60.
48. Krugman S, Giles JP, Friedman H, et al. Studies on immunity to measles. J Pediatr 1965;66:471-88.
49. Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis 1983;5:477-81.
50. Feldman W. Measles vaccination policy. Can J Public Health 1992;83:108.
51. Miller C. Live measles vaccine: A 21 year follow up. BMJ 1987;295:22-4.
52. Ramsay MEB, Moffatt D, O'Connor M. Measles vaccine: A 27-year follow-up. Epidemiol Infect 1994;112:409-12.
53. Panum PL. Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Medical Classics 1939;3:829-86.
54. Hethcote HW. Measles and rubella in the United States. Am J Epidemiol 1983;117:2-13.
55. Brown P, Gajdusek CD, Tsai T. Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine. Am J Epidemiol 1969;90:514-18.
56. Bin D, Zhihui C, Qichang L, et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ 1991;69:415-23.
57. Cote TR, Sivertson D, Horan JM, et al. Evaluation of a 2-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes. Public Health Rep 1993;108: 431-5
58. Edmonson MB, Addiss DG, McPherson T, et al. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990;263:2467-71.
59. Ozanne G, D'Halewyn M-A. Secondary immune response in a vaccinated population during a large measles epidemic. J Clin Microbiol 1992;30:1778-82.
60. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: Reevaluation of protective titers. J Infect Dis 1990;162:1036-42.
61. Erdman DD, Heath JL, Watson JC, et al. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol 1993;41:44-8.
62. Hidaka Y, Aoki T, Akeda H, et al. Serological and clinical characteristics of measles vaccine failure in Japan. Scand J Infect Dis 1994;26:725-30.
63. Erdman DD, Heath JL, Watson JC, et al. Immunoglobulin M antibody response to measles virus following primary and secondary vacination and natural virus infection. J Med Virol 1993;41:44-8.
64. Aaby P, Bukh J, Leeroy J, Lisse IM, et al. Vaccinated children get milder measles infection: A community study from Guinea-Bissau. J Infect Dis 1986;154:858-63.
65. Gray D, Skarvall H. B-cell memory is short-lived in the absence of antigen. [Letter]. Nature 1988;336:70-3.
66. Melnick JL. Virus vaccines: principles and prospects. Bull World Health Organ 1989;67:105-12.
67. Martin CM, Manfredonia SJ, Webb NC, et al. Controlled trial of live measles vaccine: Effects of age, history of measles in siblings, prevaccine antibody, and human gammaglobulin on symptomatic and immune responses. Am J Pediatr Dis Child 1963;106:267-79.
68. Peltola H, Davidkin I, Valle M, et al. No measles in Finland. Lancet 1997;350:1364-5.